Beta Bionics, Inc. — Director's Dealing 2026

Jan 7, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2026-01-06

Reporting Person: Mensinger Mike (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-06	Common Stock	S	2200	$30.1005	Disposed	80752	Direct

Footnotes

F1: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.

F2: The weighted average sale price for the transaction reported was $30.1005 and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.